Online Cognitive and Behavioural Therapy for Insomnia in Australian General Practice: An Implementation Trial

The Adelaide Institute for Sleep Health, Flinders University0 个研究点目标入组 375 人开始时间: 2019年11月7日最近更新: 2021年2月1日

适应症

试验速览

暂无简介。

•General Practitioner Inclusion Criteria;
•1. Currently using the Doctors Control Panel software
•Patient Inclusion Criteria
•1. Age > 18 years.
•2. Reliable access to computer, tablet or smartphone, with internet access
•3. Basic English language comprehension as required for Sleepio.
•Group 1 New Insomnia - No GP prescriptions of Temazepam, Oxazepam, Nitrazepam, Zolpidem, Zopiclone, or Melatonin in the past 12 months,
•Group 2 Single Sleeping Pill Prescription - One GP prescription of Temazepam, Oxazepam, Nitrazepam, Zolpidem, Zopiclone, or Melatonin in the past 12 months,
•Group 3 Repeat Sleeping Pill Prescriptions - Any combination of two or more GP prescriptions of Temazepam, Oxazepam, Nitrazepam, Zolpidem, Zopiclone, or Melatonin in the past 12 months.

•Patient Exclusion Criteria (assessed by treating GPs, according to RACGP/Sleepio recommendations);
•1. Drug or alcohol problems
•2. Terminal illness
•3. Acute crisis
•4. Risk of suicide
•5. Severe mental illness
•6. Organic brain disease
•7. Epilepsy requiring benzodiazepine as part of anticonvulsant therapy
•8. Benzodiazepine prescriptions for muscle spasms
•9. Women who are currently pregnant
•Patient Exclusion Criteria (Assessed via online self-reported screening questionnaire):
•1. Any previous diagnosis of Obstructive Sleep Apnea, Restless Legs Syndrome, or REM Behaviour Disorder.

发起方

The Adelaide Institute for Sleep Health, Flinders University